These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16012280)

  • 1. Aripiprazole in schizophrenia with cocaine dependence: a pilot study.
    Beresford TP; Clapp L; Martin B; Wiberg JL; Alfers J; Beresford HF
    J Clin Psychopharmacol; 2005 Aug; 25(4):363-6. PubMed ID: 16012280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
    Brown ES; Jeffress J; Liggin JD; Garza M; Beard L
    J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence.
    Beresford T; Buchanan J; Thumm EB; Emrick C; Weitzenkamp D; Ronan PJ
    J Clin Psychopharmacol; 2017 Dec; 37(6):657-663. PubMed ID: 28984746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole and ropinirole treatment for cocaine dependence: evidence from a pilot study.
    Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
    Curr Pharm Des; 2011; 17(14):1376-83. PubMed ID: 21524261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.
    Smelson DA; Ziedonis D; Williams J; Losonczy MF; Williams J; Steinberg ML; Kaune M
    J Clin Psychopharmacol; 2006 Feb; 26(1):9-12. PubMed ID: 16415698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
    Glick ID; Poyurovsky M; Ivanova O; Koran LM
    J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
    Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
    J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
    Han DH; Kim SM; Choi JE; Min KJ; Renshaw PF
    J Psychopharmacol; 2013 Mar; 27(3):282-91. PubMed ID: 23325372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole, alcohol and substance abuse: a review.
    Brunetti M; Di Tizio L; Dezi S; Pozzi G; Grandinetti P; Martinotti G
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1346-54. PubMed ID: 23104650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
    Stern RG; Petti TA; Bopp K; Tobia A
    J Clin Psychopharmacol; 2009 Jun; 29(3):206-9. PubMed ID: 19440071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study.
    Meini M; Moncini M; Cecconi D; Cellesi V; Biasci L; Simoni G; Ameglio M; Pellegrini M; Forgione RN; Rucci P
    Am J Addict; 2011; 20(2):179-80. PubMed ID: 21314764
    [No Abstract]   [Full Text] [Related]  

  • 12. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in bipolar disorder and cocaine dependence.
    Brown ES; Nejtek VA; Perantie DC; Bobadilla L
    Bipolar Disord; 2002 Dec; 4(6):406-11. PubMed ID: 12519101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study.
    Janiri L; Martinotti G; Di Nicola M
    J Clin Psychopharmacol; 2007 Oct; 27(5):519-20. PubMed ID: 17873691
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole in psychosis associated with Parkinson's disease.
    López-Meza E; Ruiz-Chow A; Ramirez-Bermudez J
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):421-2. PubMed ID: 16179668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
    Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
    J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.